Middle East & Africa Human Papilloma Virus Testing Market Size & Outlook
Related Markets
MEA human papilloma virus testing market highlights
- The MEA human papilloma virus testing market generated a revenue of USD 91.3 million in 2024.
- The market is expected to grow at a CAGR of 14.7% from 2025 to 2033.
- In terms of segment, cervical cancer screening was the largest revenue generating application in 2024.
- Cervical Cancer Screening is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, Kuwait is expected to register the highest CAGR from 2025 to 2033.
MEA data book summary
| Market revenue in 2024 | USD 91.3 million |
| Market revenue in 2033 | USD 307.3 million |
| Growth rate | 14.7% (CAGR from 2025 to 2033) |
| Largest segment | Cervical cancer screening |
| Fastest growing segment | Cervical Cancer Screening |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cervical Cancer Screening, Vaginal Cancer Screening |
| Key market players worldwide | Abbott Laboratories, Biomedical Diagnostics, BioMerieux SA, CeMines, Bio-Rad Laboratories Inc, Epigenomics AG, Fujirebio Diagnostics, Guided Therapeutics Inc, Oncolab, Hologic Inc, Qiagen NV, Radiant Pharmaceuticals, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR |
Other key industry trends
- In terms of revenue, MEA region accounted for 5.2% of the global human papilloma virus testing market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,399.0 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Human Papilloma Virus Testing Market Scope
Human Papilloma Virus Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Radiant Pharmaceuticals | View profile | 1001-5000 | Dhaka, Dhaka, Bangladesh, Asia | http://www.radiantpharmabd.com |
| Oncolab | View profile | 1-10 | Boston, Massachusetts, United States, North America | http://oncolabinc.com/index.html |
| CeMines | View profile | 1-10 | Evergreen, Colorado, United States, North America | http://www.cemines.com |
| Biomedical Diagnostics | View profile | 1-10 | Antwerp, Antwerpen, Belgium, Europe | https://www.bmd.be/ |
| Fujirebio Diagnostics | View profile | 5001-10000 | Malvern, Pennsylvania, United States, North America | http://www.fdi.com/ |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| Guided Therapeutics Inc | View profile | 4 | 5835 Peachtree Corners East, Suite B, Norcross, GA, United States, 30092 | https://www.guidedinc.com |
| Epigenomics AG | View profile | 18 | Geneststrasse 5, Berlin, BB, Germany, 10829 | https://www.epigenomics.com |
| Hologic Inc | View profile | 6990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | http://www.hologic.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
Middle East & Africa human papilloma virus testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to human papilloma virus testing market will help companies and investors design strategic landscapes.
Cervical cancer screening was the largest segment with a revenue share of 86.97% in 2024. Horizon Databook has segmented the Middle East & Africa human papilloma virus testing market based on cervical cancer screening, vaginal cancer screening covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Middle East & Africa human papilloma virus testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa human papilloma virus testing market databook
-
Our clientele includes a mix of human papilloma virus testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa human papilloma virus testing market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa human papilloma virus testing market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
MEA human papilloma virus testing market size, by country, 2021-2033 (US$M)
Middle East & Africa Human Papilloma Virus Testing Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
